In the search for Onchocerca volvulus antigens possibly involved in protection against human onchocerciasis, partial amino acid sequence analysis of one of the O. volvulus antigens of the serologically identified proteins showed a close relationship to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein family. Subsequent adult worm cDNA library screening and cloning produced a clone of 1650
Introduction
The parasitic nematode, Onchocerca volvulus, is a major cause of blindness and dermal pathology in the tropics. Chemotherapy with the microfilaricidal drug ivermectin, which is the backbone of the present African Programme for Onchocerciasis Control, even in combination with vector control by larvicides, cannot eradicate the parasite reservoir from hyperendemic areas in West Africa [1] . Since bovine onchocerciasis is a vaccine-preventable disease [2] , it has been proposed that in combination with these control measures, a vaccine might fully stop transmission as well as disease. Using DNA for vaccination greatly simplifies vaccine development and production, as DNA vaccines remain stable under local conditions, presumably without a cold chain [3] . Several antigens of O. volvulus, for example the DNA-construct of the O. volvulus chitinase [4] , have been shown to induce significant protection in animal models. One of the major vaccine candidates against the human pathogenic trematode Schistosoma mansoni was identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [5, 6] . GAPDH has been suggested as major therapeutical target in several parasitic diseases, as a vaccine candidate or as a target for chemotherapeutic treatment. This has been primarily attributed to the role of GAPDH as a key enzyme in glycolysis and gluconeogenesis, thus being crucial in energy production. Here we report the characterization of the O. volvulus GAPDH as well as the immune response of cattle against the DNA-construct of the coding sequence of the GAPDH of O. volvulus.
Materials and methods

Study population
After informed consent residents of West African areas endemic for onchocerciasis in Liberia, Benin and Guinea underwent physical and parasitological examinations, essentially as described [7] . The study procedures were in accordance with the Declaration of Helsinki (1975 and its revisions in 1983 and 2000).
Parasite preparation
Adult O. volvulus worms were obtained by collagenase digestion from nodules surgically removed from Liberian patients as previously described [8] . Onchocercomas embedded in paraffin were available from several studies in Liberia, Ghana, and Uganda [9] [10] [11] . The extirpation of onchocercomas for research had been approved by the Medical Board, Hamburg, Germany, and by authorities in the African countries. Nodules with adult Onchocerca ochengi had been collected from cattle in Ngaoundere in Cameroon (supplied by PD. Dr. A. Renz, University of Tqbingen, Germany). For the examination of infective larvae, we used Simulium yahense that had been reared from pupae and had been experimentally infected with O. volvulus in Guinea (supplied by Dr. T. Kruppa, BNI Hamburg) or S. soubrense from Liberia (supplied by PD Dr. G. Strote, formerly BNI Hamburg).
Identification of the Ov-GAPDH cDNA and protein expression
A E ZapII expression cDNA library, prepared from adult O. volvulus mRNA, was screened with a 32 P-labelled 970 bp probe coding for Ov-GAPDH. The probe was obtained by PCR amplification of O. volvulus cDNA using primers derived from conserved regions of known GAPDH nucleotide sequences. After plaque purification inserts were subcloned into phagemids (pBluescript II SK, Stratagene, Heidelberg, Germany) for sequencing using the in vivo excision protocols as supplied by the manufacturer (Stratagene).
PCR was carried out using synthetic oligonucleotides spanning the entire coding region of the Ov-GAPDH cDNA. The obtained fragment was digested with the appropriate restriction enzymes and cloned into the pJC45Flag expression vector modified according to Clos and Brandau [12] . Expression was performed in Escherichia coli strain PAPlacl Q (DE3) according to Clos and Brandau [12] . The further purification of the recombinant protein by Ni 2+ chelate chromatography and pH-shift under denaturing conditions was performed according to the pET manual (Novagen, Madison, WI, USA).
DNA sequence analysis
In order to identify the genomic structure of Ov-GAPDH, an O. volvulus E FiXII-gDNA library was screened using the same screening method as described above. Manual sequencing was carried out employing the dideoxynucleotide chain termination method of Sanger et al. [13] using the appropriate vector primer and synthetic internal primers deduced from the partial sequence of the clone. Sequence analysis was performed in both orientations. Automated sequencing was performed on an Applied Biosystems automated DNA sequencer. The derived sequence was compared with the public protein and nucleotide database (Genbank) by using the BLASTn and BLASTx algorithms. The DNA sequence of Ov-GAPDH was deposited in GenBank (accession no.Y09455).
Southern blot analysis
Human DNA was prepared from HL60 cells and O. volvulus DNA from adult female worms. The isolation and preparation of the DNA was done as described [14] . The Southern blot analysis was carried out by standard methods using the entire cDNA of Ov-GAPDH as a probe. The Southern blot was prepared by separation of approximately 10 Ag human and adult O. volvulus EcoRI and HindIII restricted genomic DNA on an 1% agarose gel. After depurination, denaturation and neutralization, separated DNA was transferred to nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany). The filter was hybridized overnight at 55 8C using a radioactively labelled probe.
Western blotting
The purified recombinant antigen was separated by SDS-PAGE in a 10% acrylamide gel based according to standard methods. Nitrocellulose strips were incubated with sera at different dilutions and a 1:1000 dilution of goat anti-rabbit IgG (H+L) horseradish peroxidase conjugate (HRP) (Biorad, Munich, Germany) and developed using 4-chloro-naphtol/H 2 O 2 .
Enzyme-linked enzyme immunoassy (ELISA)
For antibody analysis, wells of Maxisorb plates (Nunc, Wiesbaden, Germany) were coated at 37 8C with purified Ov-GAPDH in carbonate-bicarbonate buffer, pH 9.6, 2 Ag/ well. After incubation with the primary antibody as secondary reagent, horseradish peroxidase-conjugated goat-anti-rabbit IgG (Sigma, Deisenhof, Germany) was applied. The substrate was tetramethyl-benzidine (Sigma). The absorbance was read at 450 nm.
Synthesis of cDNA
Total O. ochengi RNA was isolated with an RNA extraction reagent (TRIzol Reagent, Gibco, Karlsruhe, Germany) and cDNA was obtained by reverse transcription using oligo-dT primers. cDNA from O. volvulus L3 was derived from a ZAPII O. volvulus cDNA library. PCR amplification was primed with a deduced GAPDH primer set, obtained by sequence comparison of highly conserved regions, such as the ATP binding site and NAD + binding site of members of the GAPDH protein family.
Enzymatic analysis of the recombinant protein
The activity of the GAPDH enzyme was determined by measuring the decrease in absorbance of NADH at a wavelength of 340 nm. Tests were performed on the recombinantly expressed Ov-GAPDH. Rabbit GAPDH (Sigma) was used as positive and nonrecombinant pJC40 vector as negative control.
Plasminogen-binding assay
Binding of human plasminogen (Sigma) was performed using human plasminogen followed by anti-plasminogen antibodies and secondary antibodies conjugated with peroxidase. In blot-overlay assays plasminogen-binding activity was detected by incubation of the membrane with a substrate solution containing 1 mg/ml 4-chloro-1-naphthol (Sigma) and 0.1% H 2 O 2 in PBS. Control experiments were performed as described using proteins from Streptococcus pneumoniae serotype 2 strain and deletion mutants as described [15] .
Immunohistology
Onchocercomas had been fixed in 80% ethanol, 4% buffered formaldehyde or Karnovsky solution (2% paraformaldehyde and 0.025% glutaraldehyde) and embedded in paraffin. Blackflies with infective larvae of O. volvulus had been fixed in 80% ethanol or Bouin solution. For immunohistology the alkaline phosphatase anti-alkaline phosphatase (APAAP) method was applied according to the recommendations given by the manufacturer (DakoCytomation, Hamburg, Germany). Polyclonal antibodies against rOV-GAPDH were raised by three consecutive immunizations of a rabbit with 100 Ag recombinant Ov-GAPDH. The immunization was performed in the facilities of Eurogentec (Ougree, Belgium). The rabbit polyclonal antibody against rOv-GAPDH was used as primary antibody diluted 1:200. As secondary antibody anti-rabbit mouse immunoglobulins (clone MR12/53, DakoCytomation) were applied. Fast Red TR salt (Sigma) was used as chromogen, and haematoxylin (Merck, Darmstadt, Germany) as counterstaining. As negative controls the preimmune serum from the immunized rabbit and human AB-serum were used. To examine the specificity, the Ov-GAPDH antibodies were absorbed from the rabbit serum or from human O. volvulus sera using the purified rOv-GAPDH antigen transferred to nitrocellulose membrane and subsequently tested by immunoblotting. The eluted antibodies showed recognition of the rOvGAPDH as well as of a corresponding single band of 36 kDa in O. volvulus worm extract. For immunohistology they were used as primary antibodies diluted 1:5.
Cloning and purification of the Ov-GAPDH DNA vaccination construct
The entire coding region of the Ov-GAPDH was cloned into the BamH1 and Not1 restriction sites of the vaccination vector pcDNA3.1(+) (Invitrogen). The Ov-GAPDHpcDNA3.1(+) was then transformed into DH5a cells, followed by bidirectional sequence analysis for proof reading purposes. Plasmid-DNA for immunization was obtained by fermentation. For purification of Ov-GAPDHpcDNA3.1(+) ion-exchange chromatography was performed using the Nucleobond PC Prep-100 kit (MachereyNagel, Dqren, Germany), following the protocol of the manufacturer.
Immunization of rabbits and cattle
For gene gun immunization, plasmid DNA was precipitated onto gold beads (1.6 Am diameter) at a ratio of 1 Ag/mg gold. In all experiments rabbits and cattle were bled before DNA immunization to collect preimmune samples for antibody assays. Rabbits were DNA immunized on day 1 and boosted on days 33 and 69. Twenty-four shots of 0.2 Ag Ov-GAPDH-pcDNA3.1(+) were applied into the shaved back using a Helios gene-gun (Biorad). Following the protocol of the manufacturer, a pressure of 300 psi was used. A similar protocol was applied for gene gun immunization of two calves using for each immunization on days 1, 27, and 66, ten shots of 1.25 Ag of Ov-GAPDH-pcDNA3.1(+) and a pressure of 300 psi. The shots were applied intradermally into the shaved skin of the neck.
Results
Cloning and sequence analysis of Ov-GAPDH
To identify O. volvulus antigens possibly involved in protection, partial amino acid (AA) sequence analysis of an O. volvulus antigen showed a close relationship to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein family. Subsequent screening of an O. volvulus adult worm cDNA library using the GAPDH-specific PCR fragment resulted in a clone of 1650 bp. An open reading frame spans over 1020 bp coding for a protein of 340 AA with an apparent molecular weight of 38 000.
Comparison of the deduced AA sequence indicated a high level of identity to members of the GAPDH protein family (74% to human GAPDH) [16] . Furthermore, Genbank comparison as well as the presumptive AA TGA GTT TTG GTA TCT  181  240  AAA AAA ATT TCC TCA AAT TCA GAT TTG GTC GTA TCG GCC GAC TTG TTT TGA GAG CGG CAG  241  300  TTG AAA AGG ACA CCG TTG AAG TAG TGG CTG TCA ATG ACC CCT TCA TCA ACA TCG ATT ACA  301  360  TGG TAT ACA TGT TCA AAT ACG ACT CAA CAC ATG GAC GCT TTA AGG GTC ATG TTT CTG CTG  361  420  AGG GTG GAA AGC TTA TTG TAA CAA ACG GCA AAA CGA CTC ATC AAA TCG CTG TAC ACA ACA  421  480  GCA AAG ATC CTG CCG AAA TTC CAT GGG GAG TAG AAG GTG CAG AAT ATG TTG TCG AAT CTA  481  540  CTG GTG TTT TAC AAC AAC GGA GAA AGC AAG CGC ACA TCT GAA GGG TGG CGC TAA GAA AGT  541  600  CAT CAT TTC GGC TCC ATC TGC TGA TGC ACC GAT GTT CGT AAT GGG TGT TAA CAA CGA CAA  601  660  GTA TGA TAA AGC AAA CAA TCA CAT CAT CTC TAA TGC TTC ATG CAC CAC CAA TTG TCT GGC  661  720  GCC ATT GGC TAA GGT TAT CCA TGA TAA ATT TGG TAT CAT CGA GGG TTT GAT GAC CAC CGT  721  780  ACA TGC AAC AAC GGC CAC TCA GAA GAC TGT TGA TGG ACC ATC TGG AAA GTT GTG GCG AGA  781  840  TGG TCG AGG TGC TGG TCA GAA CAT CAT CCC AGC AAG TAC TGG TGC AGC AAA GGC TGT AGG  841  900  AAA AGT CAT TCC GGA TCT GAA TGG AAA GCT AAC TGG AAT GGC TTT CCG TGT GCC AAC TCC  901  960  GGA CGT ATC AGT TGT TGA TCT CAC TTG CCG ACT GCA GAA AGG TGC AAG TAT GGA TGA AAT  961  1020  TAA GGC CGC TGT GAA AGA GGC AGC TGC TGG ACC AAT GAA GGG AAT TCT GGA ATA TAC TGA  1021  1080  GGA CCA GGT ATG AGT TCC GAT TTT TTG TTC AAA GCA AGT TTA ATT TCA AAA TCA TAA TGA  1081  1140  TAA ACA TTG AAG ATA ATT TGT TCT TTC TCT GAA GAT TCA GAT TGA GTT GCT TAT TTC TTT  1141  1200  GCT TGT TCG TGC AAC AAA CAG TTG CAT AAA AAG TTA TTT CCA AGA TTA ATT TTA TGA ATG  1201  1260  CTG TTC CAA ATG ACT TAC CAT AAT TTC AGG TTG TAT CAT CTG ATT TCG TTG GTG ATC CAC  1261  1320  ATT CAT CAA TCT TTG ATG CTC TGG CAT GCA TTT CAC TGA ATC CAA ACT TCG TTA AAT TGA  1321  1380  TTG CTT GGT ACG ATA ATG AAT ATG GCT ACA GCA ACC GTG TTG TTG ACC TTA TCT CTT ACA  1381  1394  TCG CGA GCA AAT AA  1395 1431 GCAGCAGTGG TACAACACTG TCATCATGGG CTTGATC Fig. 1 . Nucleotide sequence of the Ov-GAPDH gene with the 5V and 3V flanking regions. The coding region starts at nt 1 and ends at nt 1394 and contains two introns (underlined). A putative promotor sequence TGTTG at position À40 to À36 is also underlined.
sequences for an ATP and NAD + binding site and Sloop confirmed the relationship of the deduced AA sequence to the GAPDH family. Finally, the proof of the enzymatic activity and plasminogen-binding capacity of the recombinant protein allowed designation of cDNA clone Ov-GAPDH.
Genomic structure
Following a 5V-noncoding region of bps 391, the coding region of Ov-GAPDH is interrupted by 2 introns, with the length of bps 173 of intron I and bps 202 of intron II, followed by a 3V-noncoding region of bps 36 (Fig. 1) . The untranslated region contains a CAATT sequence at position À87 to À83, an AT-rich region at position À40 to À21 and a TGTTG promoter sequence at position À40 to À36, indicating the presence of the complete gene. The introns indicate the eukaryotic origin of the Ov-GAPDH sequence.
Characterization of the genomic structure of Ov-GAPDH by Southern blot analysis revealed a hybridization pattern of two bands (Fig. 2, lanes 1 and 3) . Control experiments showed no hybridization of an Ov-GAPDH cDNA probe to human genomic DNA (Fig. 2, lanes 2 and 4) , confirming the parasite origin of the GAPDH. Since the cDNA contains single sites for the used restriction enzymes EcoRI as well as HindIII, it suggests the existence of a single copy gene. This is supported by analysis of the gene structure obtained from nine clones of a FiXII-gDNA library of O. volvulus which shows also no isoforms of the enzyme.
Since the Ov-GAPDH will be used as a vaccine candidate antigen in the O. ochengi/cattle model, a corresponding GAPDH cDNA clone of O. ochengi was isolated and characterized for DNA and AA sequence comparison. The deduced O. ochengi AA sequence shows a 99.1% identity to the AA sequence of Ov-GAPDH.
Analysis of enzymatic activity of Ov-GAPDH and binding analysis of human plasminogen
To analyze whether the purified recombinant Ov-GAPDH is biologically active, assays for GAPDH enzymatic activity were performed. The NADH-enzyme activity was determined at 740 AM/min/mg GAPDH, representing a moderate activity level.
Since GAPDH has been localized on the surface of bacteria and was shown to bind plasminogen [15, 17] , the plasminogen-binding activity of the purified recombinant Ov-GAPDH was also examined. The plasminogen-binding property of group A streptococci and pneumococci and subsequent activation facilitate the penetration of the pathogen during the invasive infection process [18] . The plasminogen blot-overlay assay revealed binding activity of Ov-GAPDH as demonstrated in Fig. 3 . 
Immunolocalization
Immunohistological expression of Ov-GAPDH was demonstrated in adult male (Fig. 4A) and female O. volvulus (Fig. 4B-F) , in microfilariae in nodule tissues (Fig. 4G ) and in infective larvae in blackflies (Fig. 4H-J) . Both the serum from the immunized rabbit as well as the affinity purified antibodies produced a distinct labelling pattern, while no labelling was observed after application of the preimmune serum or the human AB-serum (not shown).
In all sections of adult filariae, most striking was the labelling of the afibrillary compartment of the muscles of the body wall, where the mitochondria are (Fig. 4A-B) , and of the uterus (Fig. 4D) . The hypodermis was usually labelled to a lesser extent whereby often only the outer zone was labelled where the folding of the cell membrane forms a labyrinth in the vicinity of the cuticle (Fig. 4A) . Occasionally, the outer as well as the inner labyrinths of the hypodermis were labelled (Fig. 4C) . Labelling of some nuclei was also observed in the uterus epithelium (Fig. 4E) . Labelling of the fluid in the pseudocoeloma cavity was detected in cross sections of a greater number of male worms and of some females (Fig. 4F) , possibly indicating release of Ov-GAPDH into the extracellular space. The epithelia of the genital tracts of both male (Fig. 4A ) and female worms (Fig. 4D) were clearly labelled in some worms. Differences in labelling were also observed within one worm section whereby one of the uterus branches was labelled but the other one not. Thus, differences in labelling appear to correlate with the actual presence of Ov-GAPDH and are not due to a variation in the fixation or preservation of the examined tissues. Rarely, weak labelling of the intestine was observed. No specific labelling was detected in the cuticle, in the fibrillar compartment of the body wall muscles, in all stages of sperms (Fig. 4A ) and in the Wolbachia endobacteria. A similar labelling pattern was observed in adult O. ochengi (data not shown).
In developmental stages of O. volvulus labelling of oocytes (Fig. 4D ) and developing embryos in the uterus varied. In infective larvae the afibrillar compartment of the muscles was always strongly labelled whereas the hypodermis was labelled to a lesser extent (Fig. 4J) . In several sections distinct labelling of some nuclei of the hypodermis was observed whereas other adjacent nuclei were not labelled.
DNA immunization of rabbits and cattle
The gene gun immunization of rabbits and cattle was well tolerated; the sites of immunization showed no adverse reactions. To examine the antibody reactivity of rabbits and cattle to the Ov-GAPDH-pcDNA3.1(+) DNA, sera of gene gun-immunized rabbits and cattle were obtained and analysed by Western blot and by ELISA. The sera of the immunized rabbits showed production of high levels of specific IgG antibody detectable at high serum dilutions by Western blot (Fig. 5A) as well as by ELISA (Fig. 5B) . Antibody levels were comparable to those obtained after DNA immunization with schistosome antigens in mice [19] . Cattle sera showed specific IgG antibody responses after week 15, which increased by week 19 (Fig. 6A) with predominance of IgG2 subclass (Fig. 6B) . 
Discussion
Here we report the isolation, characterization and expression of a full length O. volvulus cDNA sequence that encodes a 38 kDa protein. The deduced AA sequence shows high similarity with GAPDH sequences from other organisms, and the analysis of its enzymatic activity indicates that the Ov-GAPDH represents a glyceraldehyde-3-phosphate dehydrogenase. The gene of Ov-GAPDH is split by two introns. Southern blot and sequence analysis of nine independent clones indicate the presence of only one single copy of the gene in the genome of O. volvulus. This is in contrast to the genome of Caenorhabditis elegans where four GAPDH genes have been identified [20, 21] . In addition to its function in glycolysis, GAPDH was shown in various tissues of other species to be involved in functions unrelated to glycolysis. These include the bundling and unbundling of microtubules in brain tissue [22] . GAPDH has also been shown to exhibit protein kinase-like activity, leading to the phosphorylation of transverse tubule proteins which may be involved in the assembly of the junctional triads [23] .
In this study, immunohistology showed that Ov-GAPDH is present in the nuclei of the hypodermis and the uterus epithelium of the worm, whereby only a small percentage of the nuclei were labelled. Interestingly, the percentage of labelled nuclei appears to be higher in older worms, an observation which needs further analysis (Erttmann et al., in preparation) . This indicates that the Ov-GAPDH of the nucleus might have functions other than glycolysis, such as DNA replication and gene activation [24, 25] , which may be relevant in protection. GAPDH has been shown to be involved in apoptosis [26] and is viewed as a putative molecular target for the development of antiapoptotic therapeutic agents for certain neurodegenerative diseases [27] .
In this study, Ov-GAPDH was identified based on its potential involvement in protection against the parasite. Based on the same strategy, we have previously identified and characterized an O. volvulus protein named Ov-E1, which is associated with the neuronal system of the parasite and is related to the apoptotic bdeath domainQ proteins [28] . In view of the possible apoptotic functions of GAPDH and its involvement in neurodegeneration, it is intriguing to speculate that as suggested previously one point of the attack for the human immune response is the neuronal system of the parasite.
This may represent a new aspect of the role of GAPDH as a therapeutic target in helminth infections. The identification of other potential vaccine candidates suggested targeting the glycolytic pathway of the parasite, such as the O. volvulus fructose-1,6-bisphosphate aldolase [29] . Recently, another glycolytic enzyme of O. volvulus, a-enolase, has been cloned [30] . This enables the combination of these three enzymes to be tested as components of a multivalent vaccine.
The immunolocalization of Ov-GAPDH observed in this study adds new aspects regarding its role in protection. While the muscular localization of Ov-GAPDH in adult worms is consistent with its role in glycolysis and has also been reported for the O. volvulus aldolase [29] and enolase [30] , its localization in the body cavity of adult worms observed in this study as well as the detected plasminogen binding activity may indicate extracellular functions as also described in other organisms. Thus, streptococcal GAPDH has been reported on the bacterial surface [15] and appears to be involved in bacterial adhesion to host cells [31] . In schistosomes GAPDH was detected on the surface of schistosomula [32] . In O. volvulus Ov-GAPDH was detected in the larval stage by light microscopy, however, immunoelectron microscopy may be necessary to examine its more precise localization, such as in the region of the cuticle involved in larval molting, as reported for the O. volvulus aldolase [29] .
We found that Ov-GAPDH is immunogenic in natural infections with O. volvulus by analyzing the antibody response of individuals exposed to O. volvulus against rOV-GAPDH. The results show that Ov-GAPDH is a target of the immune response of putatively immune individuals as well as of a subgroup of infected individuals (Erttmann et al., manuscript in preparation). Its potential as a protective antigen is supported by the fact that it was also identified as a protective antigen against infection with schistosomes [6] . It is of interest that it has been also identified based on its association with protective antibody responses and resistance to reinfection in humans [33] . The protective potential of GAPDH in schistosomiasis has been studied in detail [34] , and antigenic determinants have been identified which can induce protective immunity [19, 33, 35] .
Vaccination strategies against schistosomes include the testing of DNA-based vaccines. Field testing of S. japonicum DNA vaccines in cattle in China showed that each of the vaccine groups could induce partial resistance [36] . In ongoing efforts to optimize immune responses associated with protection, DNA immunization regimens are being developed for several schistosome antigens in mice, showing the induction of significant B-cell and T-cell responses [19] . Our data also indicate that significant antibody responses as well as T-cell responses (Erttmann et al., in preparation) can be elicited in cattle using the Ov-GAPDH DNA immunization protocol described here. To conduct similar protection studies in Onchocerca infection using the O. ochengi/cattle model, we have cloned the O. ochengi GAPDH. The sequence is almost identical to the Ov-GAPDH and therefore greatly facilitates protection studies in cattle [2] . Further studies aimed at improvement of immunization strategies are needed to achieve an appropriate level of protection for control of O. volvulus in endemic areas.
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